The Estée Lauder Companies Inc., under the High Patronage of Mr. Emmanuel Macron, President of the French Republic, has officially opened its Fragrance Atelier within La Maison des Parfums on Rue Volney in Paris. This state-of-the-art facility represents a major…
Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging Phase 2 clinical trial results for its proprietary nasal-mucosa-optimized steroid cream, OT-007B. The therapy demonstrated rapid, durable, and clinically meaningful improvements in patients with…
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small molecule therapies that target STAT3 for the treatment of fibrosis-driven diseases, announced an update on preliminary results from its Phase 2 REVERT clinical trial of TTI-101 in patients with…
A team of scientists at Children’s Hospital Los Angeles (CHLA) has made a major breakthrough in understanding Ewing Sarcoma, a rare and aggressive cancer of the bone and soft tissue that predominantly strikes children and adolescents. Their findings provide compelling…
Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, announced the first overall survival (OS) results from Arm A1 of its Phase 2 EDGE-Gastric study. The trial evaluates domvanalimab, an Fc-silent anti-TIGIT antibody, in combination…
Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis…
Adagio Medical Holdings, Inc., a leading developer of catheter ablation technologies for cardiac arrhythmias, today announced preliminary acute safety and efficacy results from its FULCRUM-VT study, evaluating Ultralow Temperature Cryoablation (ULTC) for the treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)…
Joining world-changing breakthroughs such as YouTube, the Apple iPhone, IBM’s Watson, and the Large Hadron Collider, the Double Neural Bypass, a revolutionary brain-computer interface developed at Northwell Health’s Feinstein Institutes for Medical Research, has been inducted into TIME’s Best Inventions…
Satellos Bioscience Inc., a clinical-stage biotechnology company pioneering regenerative treatments for degenerative muscle diseases, has announced compelling new results supporting the safety, tolerability, and early signs of efficacy of its lead candidate, SAT-3247, in adults with Duchenne muscular dystrophy (DMD).…
Wysa, a global leader in AI-guided mental healthcare, has released compelling new research showing that loneliness is far more than an emotional or social issue—it is a serious clinical risk factor with deep implications for both mental and physical health.…